Genistein does not inhibit TGF-beta1-induced conversion of human dermal fibroblasts to myofibroblasts
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
34505520
PubMed Central
PMC8820530
DOI
10.33549/physiolres.934666
PII: 934666
Knihovny.cz E-zdroje
- MeSH
- fibroblasty účinky léků metabolismus MeSH
- fytoestrogeny farmakologie MeSH
- genistein farmakologie MeSH
- lidé MeSH
- preklinické hodnocení léčiv MeSH
- primární buněčná kultura MeSH
- signální transdukce účinky léků MeSH
- transformující růstový faktor beta1 antagonisté a inhibitory metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- fytoestrogeny MeSH
- genistein MeSH
- TGFB1 protein, human MeSH Prohlížeč
- transformující růstový faktor beta1 MeSH
Transforming growth factor beta 1 (TGF-beta1) is a pro-fibrotic cytokine with a key role in wound repair and regeneration, including induction of fibroblast-to-myofibroblast transition. Genistein is a naturally occurring selective estrogen receptor modulator with promising anti-fibrotic properties. In the present study we aimed to investigate whether genistein modulates TGF-beta1 (canonical and non-canonical) signaling in normal dermal fibroblasts at the protein level (Western blot and immunofluorescence). We demonstrated that TGF-beta1 induces the myofibroblast-like phenotype in the studied fibroblast signaling via canonical (SMAD) and non-canonical (AKT, ERK1/2, ROCK) pathways. Genistein induced only ERK1/2 expression, whereas the combination of TGF-beta1 and genistein attenuated the ERK1/2 and ROCK signaling. Of note, the other studied pathways remained almost unaffected. From this point of view, genistein does not impair conversion of normal fibroblasts to myofibroblast-like cells.
Zobrazit více v PubMed
ANDUGULAPATI SB, GOURISHETTI K, TIRUNAVALLI SK, SHAIKH TB, SISTLA R. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-beta mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine. 2020;78:153298. doi: 10.1016/j.phymed.2020.153298. PubMed DOI PMC
ASHCROFT GS, DODSWORTH J, Van BOXTEL E, TARNUZZER RW, HORAN MA, SCHULTZ GS, FERGUSON MW. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med. 1997;3:1209–1215. doi: 10.1038/nm1197-1209. PubMed DOI
BERMAN B, MADERAL A, RAPHAEL B. Keloids and hypertrophic scars: Pathophysiology, classification, and treatment. Dermatol Surg. 2017;43(Suppl 1):S3–S18. doi: 10.1097/DSS.0000000000000819. PubMed DOI
BERRY DP, HARDING KG, STANTON MR, JASANI B, EHRLICH HP. Human wound contraction: collagen organization, fibroblasts, and myofibroblasts. Plast Reconstr Surg. 1998;102:124–131. doi: 10.1097/00006534-199807000-00019. PubMed DOI
BRENMOEHL J, MILLER SN, HOFMANN C, VOGL D, FALK W, SCHÖLMERICH J, ROGLER G. Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. World J Gastroenterol. 2009;15:1431–1442. doi: 10.3748/wjg.15.1431. PubMed DOI PMC
CAO C, LI S, DAI X, CHEN Y, FENG Z, ZHAO Y, WU J. Genistein inhibits proliferation and functions of hypertrophic scar fibroblasts. Burns. 2009;35:89–97. doi: 10.1016/j.burns.2008.03.011. PubMed DOI
CANNITO S, NOVO E, PAROLA M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts. Adv Drug Deliv Rev. 2017;121:57–84. doi: 10.1016/j.addr.2017.05.017. PubMed DOI
CAO C, LI SR, DAI X, CHEN YQ, FENG Z, QIN X, ZHAO Y, WU J. The effects of genistein on tyrosine protein kinase-mitogen activated protein kinase signal transduction pathway in hypertrophic scar fibroblasts. (Article in Chinese) Zhonghua Shao Shang Za Zhi. 2008;24:118–121. PubMed
DERYNCK R, ZHANG YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–584. doi: 10.1038/nature02006. PubMed DOI
DIEL P, OLFF S, SCHMIDT S, MICHNA H. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7. Planta Medica. 2001;67:510–514. doi: 10.1055/s-2001-16474. PubMed DOI
DVORANKOVA B, LACINA L, SMETANA K., JR Isolation of normal fibroblasts and their cancer-associated counterparts (CAFs) for biomedical research. Methods Mol Biol. 2019;1879:393–406. doi: 10.1007/7651_2018_137. PubMed DOI
EMMERSON E, CAMPBELL L, ASHCROFT GS, HARDMAN MJ. The phytoestrogen genistein promotes wound healing by multiple independent mechanisms. Mol Cell Endocrinol. 2010;321:184–193. doi: 10.1016/j.mce.2010.02.026. PubMed DOI
HERICHOVA I, REIS R, HASAKOVA K, VICIAN M, ZEMAN M. Sex-dependent regulation of estrogen receptor beta in human colorectal cancer tissue and its relationship with clock genes and VEGF-A expression. Physiol Res. 2019;68(Suppl 3):S297–S305. doi: 10.33549/physiolres.934352. PubMed DOI
HERICHOVA I, REIS R, HASAKOVA K, VICIAN M. Downregulation of miR-30c-5p expression in colorectal cancer tissue is sex-dependent. Physiol Res. 2020;69(Suppl 3):S479–S487. doi: 10.33549/physiolres.934598. PubMed DOI PMC
HILL M, TŘÍSKALA Z, HONCŮ P, KREJČÍ M, KAJZAR J, BIČÍKOVÁ M, ONDŘEJÍKOVÁ L, JANDOVÁ D, STERZL I. Aging, hormones and receptors. Physiol Res. 2020;69(Suppl 2):S255–S272. doi: 10.33549/physiolres.934523. PubMed DOI PMC
JURZAK M, ADAMCZYK K, ANTONCZAK P, GARNCARCZYK A, KUŚMIERZ D, LATOCHA M. Evaluation of genistein ability to modulate CTGF mRNA/protein expression, genes expression of TGFbeta isoforms and expression of selected genes regulating cell cycle in keloid fibroblasts in vitro. Acta Pol Pharm. 2014;71:972–986. PubMed
KLASS BR, GROBBELAAR AO, ROLFE KJ. Transforming growth factor beta1 signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J. 2009;85:9–14. doi: 10.1136/pgmj.2008.069831. PubMed DOI
LICHTMAN MK, OTERO-VINAS M, FALANGA V. Transforming growth factor beta (TGF-beta) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016;24:215–222. doi: 10.1111/wrr.12398. PubMed DOI
MARINI H, POLITO F, ALTAVILLA D, IRRERA N, MINUTOLI L, CALÒ M, ADAMO EB, VACCARO M, SQUADRITO F, BITTO A. Genistein aglycone improves skin repair in an incisional model of wound healing: a comparison with raloxifene and oestradiol in ovariectomized rats. Br J Pharmacol. 2010;160:1185–1194. doi: 10.1111/j.1476-5381.2010.00758.x. PubMed DOI PMC
MATSUDA T, YAMAMOTO T, MURAGUCHI A, SAATCIOGLU F. Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem. 2001;276:42908–42914. doi: 10.1074/jbc.M105316200. PubMed DOI
NING Y, CHEN J, SHI Y, SONG N, YU X, FANG Y, DING X. Genistein ameliorates renal fibrosis through regulation snail via m6A RNA demethylase ALKBH5. Front Pharmacol. 2020;11:579265. doi: 10.3389/fphar.2020.579265. PubMed DOI PMC
PAKSHIR P, NOSKOVICOVA N, LODYGA M, SON DO, SCHUSTER R, GOODWIN A, KARVONEN H, HINZ B. The myofibroblast at a glance. J Cell Sci. 2020;133:jcs227900. doi: 10.1242/jcs.227900. PubMed DOI
SHI X, YOUNG CD, ZHOU H, WANG X. Transforming growth factor-beta signaling in fibrotic diseases and cancer-associated fibroblasts. Biomolecules. 2020;10:1666. doi: 10.3390/biom10121666. PubMed DOI PMC
YUAN WJ, JIA FY, MENG JZ. Effects of genistein on secretion of extracellular matrix components and transforming growth factor beta in high-glucose-cultured rat mesangial cells. J Artif Organs. 2009;12:242–246. doi: 10.1007/s10047-009-0479-y. PubMed DOI